Study of Antibiotic Utilization Measures and Control of ESBLs in China

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

ICU Patient

Interventions

DRUG

Third generation cephalosporins

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488813 - Study of Antibiotic Utilization Measures and Control of ESBLs in China | Biotech Hunter | Biotech Hunter